AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr | ₹468 Cr |
What is the latest Consolidated Net Profit of AJANTA PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹816 Cr |
Mar2023 | ₹588 Cr |
Mar2022 | ₹713 Cr |
Mar2021 | ₹654 Cr |
Mar2020 | ₹468 Cr |
How is Consolidated Net Profit of AJANTA PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹816 Cr | 38.81 | |
Mar2023 | ₹588 Cr | -17.50 | |
Mar2022 | ₹713 Cr | 8.99 | |
Mar2021 | ₹654 Cr | 39.81 | |
Mar2020 | ₹468 Cr | - |
Compare Consolidated Net Profit of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹33,708.0 Cr | -0.7% | -8% | 22.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.7% |
-8% |
22.9% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses